Elutia Inc. (ELUT)
NASDAQ: ELUT · Real-Time Price · USD
0.8423
+0.0248 (3.03%)
At close: Jan 20, 2026, 4:00 PM EST
0.8347
-0.0076 (-0.90%)
After-hours: Jan 20, 2026, 7:48 PM EST
Elutia Revenue
Elutia had revenue of $3.32M in the quarter ending September 30, 2025, a decrease of -9.26%. This brings the company's revenue in the last twelve months to $21.08M, down -6.38% year-over-year. In the year 2024, Elutia had annual revenue of $24.38M, down -1.50%.
Revenue (ttm)
$21.08M
Revenue Growth
-6.38%
P/S Ratio
1.53
Revenue / Employee
$426,392
Employees
51
Market Cap
36.05M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 24.38M | -370.00K | -1.50% |
| Dec 31, 2023 | 24.75M | 896.00K | 3.76% |
| Dec 31, 2022 | 23.85M | -23.54M | -49.68% |
| Dec 31, 2021 | 47.39M | 4.71M | 11.03% |
| Dec 31, 2020 | 42.68M | -219.00K | -0.51% |
| Dec 31, 2019 | 42.90M | 3.86M | 9.90% |
| Dec 31, 2018 | 39.04M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| TELA Bio | 77.06M |
| Myomo | 41.64M |
| Cytosorbents | 36.98M |
| Baird Medical Investment Holdings | 31.86M |
| Spectral AI | 23.17M |
| NeuroOne Medical Technologies | 12.10M |
| IceCure Medical | 2.98M |
| VolitionRx | 1.47M |
ELUT News
- 8 days ago - Elutia Reports Preliminary Fourth Quarter 2025 Results, Strengthened Financial Position, and Upcoming NXT-41x Milestones - GlobeNewsWire
- 11 days ago - Elutia to Present at Global BioInnovation Forum on NXT-41x Biomatrix Program for Plastic and Reconstructive Surgery - GlobeNewsWire
- 2 months ago - Elutia Inc. (ELUT) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Elutia Reports Third Quarter 2025 Financial Results; Closes $88 Million Sale of BioEnvelope Business to Boston Scientific Corporation; Funds NXT-41x Development - GlobeNewsWire
- 3 months ago - Elutia to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025 - GlobeNewsWire
- 3 months ago - Elutia to Present at the LD Micro Main Event XIX Conference on Tuesday, October 21 - GlobeNewsWire
- 3 months ago - Elutia Appoints Accomplished MedTech Veteran Guido J. Neels to Board of Directors - GlobeNewsWire
- 3 months ago - Elutia Announces Closing of BioEnvelope Business Sale to Boston Scientific Corporation for $88 Million - GlobeNewsWire